9 results
DEFA14A
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
Additional proxy soliciting materials
9:14am
% in MMD during the weeks 21 to 24 of the treatment period, changes in use of escape medications from baseline, certain safety endpoints and other patient
8-K
EX-99.2
b6kjln 3hz
13 Dec 22
Entry into a Material Definitive Agreement
9:46am
- Prev
- 1
- Next